Search Results

Lancaster University in the UK receives EPSRC funding to study antimatter production in intense laser pulses

Christopher Arran, a lecturer at Lancaster University and the Cockcroft Institute in the UK, has recently been awarded a three-year New Investigator Award from the UK Engineering and Physical Sciences Research Council (EPSRC) to study electron-positron pair production in the extremely intense electromagnetic fields of high-power lasers. The research focuses on matter-antimatter production processes under intense laser pulse conditions. Similar interactions are believed to exist in extreme cosmic environments, such as near pulsars and black hole accretion disks. Previously, such interactions had only been measured at large particle accelerator facilities such as Stanford University and the European Organization for Nuclear Research (CERN), but the electric and magnetic field strengths used in those experiments were far weaker than the strong-field conditions achievable with current high-power lasers.

2026-08-26

Japan's Mihama Nuclear Power Plant Unit 3 Receives Preliminary Approval for Operation Plan Beyond 50 Years

On August 25, Japan's Nuclear Regulation Authority (NRA) gave preliminary approval to Kansai Electric Power Co. (KEPCO) for the long-term facility management plan for Unit 3 of the Mihama Nuclear Power Plant. Located in Mihama Town, Fukui Prefecture, the unit will mark its 50th anniversary of commercial operation on December 1. In May of this year, the metal top cover of the high-pressure turbine at Mihama Unit 3 suffered damage, resulting in steam leakage. At the NRA meeting held that day, KEPCO explained that the cause of the incident was believed to be thinning of the inner wall of the top cover due to steam flow. The company stated that this phenomenon falls under previously anticipated aging and degradation management for turbine equipment, and that the existing plan already includes corresponding management measures. Visual inspection and other examination methods were also deemed applicable, thus no revision to the long-term facility management plan was required.

2026-08-26

Japan's TEPCO Receives 4.8 Billion Yen in Nuclear Damage Compensation Funds

Tokyo Electric Power Company Holdings (TEPCO Holdings) announced on August 24 that it received a fund disbursement of 4.8 billion yen from the Nuclear Damage Compensation and Decommissioning Facilitation Corporation (NDF) on the same day. The disbursement was made in accordance with the revised Special Business Plan approved on March 31, 2026. TEPCO stated that, to date, it has received 188.9 billion yen in compensation under the Act on Compensation for Nuclear Damage, and a cumulative total of 11.5524 trillion yen in fund disbursements from the NDF. As the total compensation payments expected by the end of September 2026 are projected to exceed the combined amount of the above funds, the company applied for the 172nd fund disbursement. TEPCO said that while receiving institutional financial support, it will continue to advance compensation efforts for nuclear accident victims and meet related compensation demands. Information on claims and payment status, changes in cumulative total payments, and agreement amounts by category is available through the company's public channels.

2026-08-24

Hitachi Receives Order for Heavy Ion Therapy System from Shanghai Proton and Heavy Ion Center

Recently, Hitachi (China) Co., Ltd. received an order for one heavy ion cancer therapy system from the Shanghai Proton and Heavy Ion Center, and the two parties held a signing ceremony. This order is part of the Phase II construction project of the Shanghai Proton and Heavy Ion Center. Rendering of the completed Phase II project of the Shanghai Proton and Heavy Ion Center The Shanghai Proton and Heavy Ion Center is the first medical institution in China to possess both proton and heavy ion radiotherapy technologies. To further meet the demand for precision medicine, the center launched its Phase II construction in 2025, planning to add particle therapy system equipment. According to the project arrangement, the heavy ion therapy system ordered this time will be equipped with 4 treatment rooms and integrate Hitachi's moving-target tracking technology and pencil-beam scanning irradiation technology.

2026-08-24

Cubresa Brain PET Scanner Receives FDA 510(k) Clearance, Integrates with Existing PET/MR Systems

Molecular imaging technology company Cubresa Inc. announced on August 20 that its Cubresa BrainPET™ scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). According to the company, the Cubresa BrainPET™ is a positron emission tomography (PET) device specifically designed for brain imaging and can be integrated into existing Siemens Biograph mMR MR/PET systems. The device enables healthcare institutions to perform simultaneous PET/MR brain imaging on existing MRI infrastructure, capturing molecular and anatomical information without the need to purchase a separate whole-body hybrid imaging system. Cubresa founder and CEO James ...

2026-08-22

Qinshan Nuclear Power Receives On-Site Visit for WANO Enhanced Performance Monitoring and Achieves Highest Rating

Recently, experts from the World Association of Nuclear Operators (WANO) Tokyo Center and Shanghai Office visited Qinshan Nuclear Power to conduct an on-site Enhanced Performance Monitoring (ePM) assessment for its nine units. Based on a comprehensive evaluation, the WANO on-site visit team unanimously concluded that Qinshan Nuclear Power has demonstrated steady overall performance improvement in recent years and currently operates at the industry's highest "benchmark" level, with expectations that performance across key areas will remain stable or continue to improve over the next six months. Additionally, WANO experts conducted follow-up evaluations on selected Areas for Improvement (AFIs) and Significant Operating Experience Report (SOER) recommendations arising from the 2025 WANO peer review of Qinshan Nuclear Power's nine units, deeming the overall results satisfactory. At a summary meeting held on August 20...

2026-08-22

German SIBAF Project Receives €9.7 Million to Support Fusion Materials Research

On August 20, 2026, with funding from the German Federal Ministry of Research, Technology and Space (BMFTR), the SIBAF project will launch the construction of an accelerator infrastructure for fusion materials research. The project, whose full name is Superconducting Ion Accelerator as a Foundational Technology for Fusion Research, will receive €9.7 million over three years, of which €8.1 million is allocated to the GSI Helmholtz Centre for Heavy Ion Research (GSI) and its Facility for Antiproton and Ion Research (FAIR), currently under construction. Goethe University Frankfurt will also participate in the project. SIBAF is part of the funding program "Fusion Foundational Technologies — Toward the Fusion Power Plant." Project objectives...

2026-08-21

Norroy Bioscience's 68Ga-NYM096 Receives FDA Breakthrough Therapy and Fast Track Designations

China-based Norroy Bioscience announced on August 19 that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to its radiopharmaceutical imaging agent 68Ga-NYM096. The agent is a PET imaging tracer targeting carbonic anhydrase IX (CAIX), intended for imaging clear cell renal cell carcinoma (ccRCC). According to the company, 68Ga-NYM096 is being developed as a non-invasive PET imaging tool to characterize renal masses detected by CT or MRI and to help distinguish clear cell renal cell carcinoma from other non-ccRCC renal lesions. Clear cell renal cell carcinoma is the most common subtype of renal cell carcinoma...

2026-08-21

Vivos Ships First Batches from U.S. IsoPet Production Facility, Receives AERB Approval to Build International Manufacturing Center in India

KENNEWICK, Wash. — Vivos Inc. recently announced two operational milestones: its in-house production facility in Richland, Washington, has begun delivering IsoPet® products to certified veterinary clinics in the United States; simultaneously, the company has received authorization from India's Atomic Energy Regulatory Board (AERB) to establish an international manufacturing center in India. This means Vivos will have a two-site production footprint spanning the U.S. and India. According to the company, the U.S. production facility, housed at the Applied Process Engineering Laboratory (APEL), will manufacture IsoPet® veterinary oncology products and RadioGel® human oncology products, and will serve as the center for subsequent process improvements and regulatory...

2026-08-19

Terra Clean Energy Receives Exploration Permit for Marysvale Uranium Project in Utah, USA

Terra Clean Energy Corp. recently announced that it has received the relevant permit from the Utah Division of Oil, Gas and Mining under the Utah Department of Natural Resources to carry out planned exploration work at its wholly-owned Marysvale Uranium Project. Under the approved work plan, the company will construct 5 drill pads to support subsequent diamond core drilling, and excavate 7 exploration trenches to expose and evaluate known uranium-bearing outcrops. Terra stated that this permit represents a significant milestone in advancing this historic uranium project. The trenching work will help the company's technical team map mineralized structures, collect samples, and validate existing geological interpretations. The results will...

2026-08-18

Turkey's TR-2 Research Reactor Receives Operating License

The Turkish Nuclear Regulatory Authority has issued an operating license for the TR-2 research reactor at the Istanbul campus of the Nuclear Energy Institute under the Turkish Energy, Nuclear and Mineral Research Agency (TENMAK). The license was issued pursuant to the Authority's Decision No. 2026-34/3 dated August 6, 2026. Following the review and evaluation of TENMAK's application documents, the Turkish Nuclear Regulatory Authority authorized the agency to carry out the activities required for the transition of the TR-2 research reactor from its current status to the operational phase. TR-2 is located at the Istanbul campus of TENMAK's Nuclear Energy Institute, with an approved thermal power of 5 megawatts. The facility is a research reactor and is not a nuclear facility primarily intended for power generation. According to...

2026-08-17

Finland's Onkalo Spent Nuclear Fuel Final Disposal Facility Expected to Receive Operating License by Year-End

Finland's spent nuclear fuel final disposal project has entered the critical stage of operating license review. The Radiation and Nuclear Safety Authority of Finland (STUK) issued a statement saying that the design and emergency response procedures of the Onkalo final disposal facility meet the safety requirements for granting an operating license. The Finnish government is expected to decide whether to approve the facility's operation before the end of the year. Onkalo is located on Olkiluoto Island in southwestern Finland. "Onkalo" means "cave" in Finnish. If licensed and operational, the facility will become the world's first deep geological final disposal facility for spent nuclear fuel from nuclear power plants, serving as a reference for other countries considering similar facilities...

2026-08-14

U.S. Company Proposes Americium-241 Radioisotope Heating Solution for Spacesuits, Receives Early NASA Research Support

U.S.-based Zeno Power Systems has proposed a radioisotope heating concept for lunar extravehicular activities, planning to use Americium-241 (Am-241) to provide continuous passive warmth for astronauts during lunar nights and in permanently shadowed regions. The proposal has been selected for this year's NASA Innovative Advanced Concepts (NIAC) program, with the potential to receive up to $175,000 in early-stage research funding. The lunar surface environment is one of the key challenges for long-duration crewed missions. Data shows that lunar nights can last approximately two weeks, and extreme low temperatures will limit the duration of astronaut extravehicular activities in shadowed areas and at night. Even with new-generation spacesuits, their cold resistance remains limited...

2026-08-13

University of Missouri Receives $1 Million Grant to Research New FLASH Radiotherapy System

On August 11, researchers at the University of Missouri School of Medicine received a $1 million grant from the National Institutes of Health to study a new technology in cancer radiotherapy—the TheryQ FLASHKNiFE system. The project is funded through June 2027. A long-standing challenge in cancer treatment is how to kill tumor cells while protecting surrounding healthy tissue as much as possible. Existing radiotherapy can already achieve millimeter-level precision, but radiation damage and related side effects still limit the dose patients can safely receive. Unlike conventional approaches, FLASH radiotherapy does not primarily alter the direction of radiation beams, but instead delivers irradiation in an extremely short time at an ultra-high dose rate...

2026-08-12

Brazil's IRD Radiometric Metrology Laboratory Receives CTBTO Certification, Joins International Nuclear Test Monitoring Network

The Radiometric Metrology Laboratory of Brazil's Institute of Radiation Protection and Dosimetry (IRD/ANSN) has recently received certification from the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO), officially qualifying it to join the international verification system. The certification was granted following an on-site audit conducted by the CTBTO in Rio de Janeiro from June 16 to 25, marking the Brazilian laboratory as the 15th certified unit among the 16 treaty-designated radionuclide laboratories. The certification primarily confirmed that the laboratory meets CTBTO requirements in high-precision analysis, result reliability, data traceability, and standardization of technical procedures. The audit covered sample reception and preparation, equipment calibration, result interpretation,...

2026-08-12